EICHOR About Solutions

Recruiting studies: Gallbladder Malignant Neoplasm

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Agnostic Therapy in Rare Solid Tumors
Phase 2 · 8 location(s) · Instituto do Cancer do Estado de São Paulo · NCT06638931 Addition of Everolimus to Standard of Care in Carcinoma Gallbladder
Phase 2/Phase 3 · 1 location(s) · Banaras Hindu University · NCT05833815 The Effect in Wedge Resection and IVb/V Resection of the Liver for Gallbladder Cancer
NA · 1 location(s) · Saint Vincent's Hospital, Korea · NCT02920554 Sequential Anti-Angiogenic Therapy After Immunotherapy in Advanced Biliary Tract Cancer
Phase 2 · 1 location(s) · First Affiliated Hospital of Zhejiang University · NCT07025174 A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Phase 1 · 12 location(s) · Pliant Therapeutics, Inc. · NCT06270706 DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adul
Phase 2/Phase 3 · 27 location(s) · Cancer Research UK · NCT05786716 Gemcitabine Hydrochloride, Cisplatin, Nab-Paclitaxel, and Durvalumab in Treating Patients With Locally Advanced or Metas
Phase 2 · 1 location(s) · Fudan University · NCT06591650 NGS in Gallbladder Cancer and Response to Treatment
Phase N/A · 1 location(s) · Banaras Hindu University · NCT05404347 Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
NA · 1 location(s) · Cedars-Sinai Medical Center · NCT04907643 Combination of Gemcitabine, Albumin-paclitaxel , Sintilimab and Bevacizumab in Unresectable Gallbladder Cancer
Phase 2 · 1 location(s) · Lu Wang, MD, PhD · NCT05757336 Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)
NA · 1 location(s) · University of California, Davis · NCT06101277 Radiation Therapy in Unresectable Gall Bladder Cancer
Phase 2/Phase 3 · 1 location(s) · Tata Memorial Centre · NCT06214572 Robotic-assisted Contra Open Resection for Suspected or Confirmed Gallbladder Cancer (ROBOCOP)
NA · 1 location(s) · Karolinska University Hospital · NCT06246448 A Single-arm Phase II Clinical Study of the Efficacy and Safety of Camrelizumab Combined With GEMOX for Unresectable GBC
Phase 2 · 1 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT06423170 Integrated Cancer Repository for Cancer Research
Phase N/A · 42 location(s) · University of Nebraska · NCT02012699 Neoadjuvant Chemotherapy for Locally Advanced Gall Bladder Cancer : a Randomized Control Trial (NEOGB)
Phase 3 · 3 location(s) · Rajiv Gandhi Cancer Institute & Research Center, India · NCT06712420 Bile Omics for Diagnosing Indeterminate Biliary Strictures
Phase N/A · 1 location(s) · Shanghai General Hospital, Shanghai Jiao Tong University Sch · NCT07007832 Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer
Phase 2 · 2 location(s) · Case Comprehensive Cancer Center · NCT07146646 The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Phase 1/Phase 2 · 77 location(s) · PMV Pharmaceuticals, Inc · NCT04585750 Prospective Evaluation of 68Ga-FAPI PET in Biliary Cancers
Phase N/A · 1 location(s) · Tata Memorial Centre · NCT07337850 Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-posi
Phase 3 · 185 location(s) · Jazz Pharmaceuticals · NCT06282575 Target-specific immunoPET Imaging of Digestive System Carcinoma
NA · 1 location(s) · RenJi Hospital · NCT06715839 Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment o
Phase 1 · 1 location(s) · City of Hope Medical Center · NCT05285358 EULAT Eradicate GBC
Phase N/A · 36 location(s) · Centre Paul Strauss · NCT06192719 A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening
Phase N/A · 1 location(s) · Yingbin Liu, MD, PhD, FACS · NCT07176962 Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
Phase 1/Phase 2 · 1 location(s) · University of Florida · NCT05000294 Safety and Efficacy of CD160-Enhanced Autologous Antigen-Specific T-Cells (BTC-Ag-T) in Advanced Biliary Tract Cancer
Phase 1 · 1 location(s) · Shanghai Zhongshan Hospital · NCT07614061 A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Parti
Phase 2 · 54 location(s) · Bayer · NCT06760819 Study on Sequential Cryoablation, Relaforp Alpha, and Chemotherapy for Bile Duct Tumors
Phase 2 · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT07726446 Identification of New Biomarkers for Patients With Cholangiocarcinoma and Gallbladder Cancer
Phase N/A · 1 location(s) · Herlev and Gentofte Hospital · NCT05184400

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →